Michelle Diane Beechamp, OTD, OT/L | |
4195 W Dublin Ct, Chandler, AZ 85226-2142 | |
(480) 241-8553 | |
Not Available |
Full Name | Michelle Diane Beechamp |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 4195 W Dublin Ct, Chandler, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891311767 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | OTH008131 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Michelle Diane Beechamp, OTD, OT/L 4195 W Dublin Ct, Chandler, AZ 85226-2142 Ph: (480) 241-8553 | Michelle Diane Beechamp, OTD, OT/L 4195 W Dublin Ct, Chandler, AZ 85226-2142 Ph: (480) 241-8553 |
News Archive
BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.
Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that its common shares will begin trading on the NASDAQ Global Select Market on June 29, 2015 under the symbol CXRX.
Researchers shed new light on the genetic relationship between three mood disorders associated with depression-major depression and bipolar disorder types 1 and 2, in a new study in the journal Biological Psychiatry, published by Elsevier.
Esophageal Squamous Cell Carcinoma (ESCC), the major histological form of esophageal cancer, is the leading cause of cancer death worldwide. Scientists from the National University of Singapore (NUS) have discovered a biomarker, called adenosine deaminase acting on RNA-1 (ADAR1), which has the potential to improve the diagnosis, prognosis and treatment of this disease.
› Verified 7 days ago
Sarah J. Whitney, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 575 W Pecos Rd Apt 1127, Chandler, AZ 85225 Phone: 602-793-1492 | |
Taylor Knoll, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 N Arizona Ave Ste 105, Chandler, AZ 85225 Phone: 480-365-9981 | |
Kendra Alaine Bauman, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Mrs. Carole Beth Gates, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6283 W Megan St, Chandler, AZ 85226 Phone: 480-634-4993 | |
Kylie Metherd, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2715 S Alma School Rd Ste 3, Chandler, AZ 85286 Phone: 480-508-5252 | |
Christine Rose Prigge, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 621 N Tercera Ave, Chandler, AZ 85226 Phone: 480-239-1595 Fax: 480-855-3507 | |
Amy Carr, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2175 N Alma School Rd Ste A106, Chandler, AZ 85224 Phone: 480-855-0474 |